Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests-Reference-Cited by-同舟云学术

Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests

Published:2000-06 Issue:11 Volume:25 Page:1147-1155
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Janssen JJWM,van Rijn RS,van der Holt B,Schuurhuis G-J,Vellenga E,Verhoef GEG,Ossenkoppele GJ,van den Berg E,Hagemeijer A,Släter R,Nieuwint AWM,Cornelissen JJ

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1702420.pdf

Reference49 articles.

1. Fialkow PJ, Jacobson RJ, Singer JW et al. Philadelphia chromosome (Ph1)-negative chronic myelogenous leukemia (CML): a clonal disease with origin in a multipotent stem cell Blood 1980 56: 70–73

2. Daley GQ, Van Etten RA, Baltimore D . Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome Science 1990 247: 824–830

3. O'Brien SG . Autografting in chronic myeloid leukaemia Baillières Clin Haematol 1997 10: 369–388

4. Allan NC, Richards SM, Shepherd PC . UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia Lancet 1995 345: 1392–1397

5. Hehlmann R, Heimpel H, Hasford J et al. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group Blood 1994 84: 4064–4077

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Stem Cell Transplantation for Chronic Myeloid Leukemia;Thomas’ Hematopoietic Cell Transplantation;2016-01-01

2. Chronic myeloid leukemia in the Netherlands: a population-based study on incidence, treatment, and survival in 3585 patients from 1989 to 2012;European Journal of Haematology;2015-11-30

3. Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era;American Journal of Hematology;2014-02

4. High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study;Annals of Hematology;2006-10-10

5. Identification of genes potentially involved in disease transformation of CML;Leukemia;2005-04-07